What ETF is Eli Lilly in?
Eli Lilly Stock Widely Held in ETFs
The best-performing fund in the past 12 months with LLY as a holding is the Fidelity Growth Opportunities ETF (FGRO), with a return of 25.48%. Novo Nordisk and Lilly are top holdings in the VanEck Pharmaceutical ETF (PPH).
Which ETF holds Eli Lilly?
Eli Lilly Stock Widely Held in ETFs
The best-performing fund in the past 12 months with LLY as a holding is the Fidelity Growth Opportunities ETF (FGRO), with a return of 25.48%. Novo Nordisk and Lilly are top holdings in the VanEck Pharmaceutical ETF (PPH).
How can I invest in Eli Lilly?
How do I purchase shares in Eli Lilly and Company? You may contact a licensed stockbroker to purchase shares or EQ Shareowner Services administers the Shareowner Services Plus Plan, which allows registered shareholders to purchase additional shares of Lilly common stock through the automatic investment of dividends.
Is Eli Lilly good stock to buy?
And this year, the company is expecting another solid performance. Eli Lilly projects that in 2024 its revenue will total between $40.4 billion and $41.6 billion. At the midpoint, that would be 20% higher than the company's revenue in 2023. That's the same growth rate as Eli Lilly generated in the past year.
What mutual funds have Eli Lilly stock?
| Name | % Total Shares Held | Date |
|---|---|---|
| Capital Group Wash Mutual Invtrs Comp | 0.71 | Dec 31, 2023 |
| American Funds Washington Mutual A | 0.71 | Dec 31, 2023 |
| Health Care Select Sector SPDR® ETF | 0.63 | Feb 27, 2024 |
| JPMorgan Large Cap Growth I | 0.61 | Dec 31, 2023 |
Who owns the most Eli Lilly stock?
| Name | Equities | % |
|---|---|---|
| Lilly Endowment, Inc. 10.42 % | 98,898,810 | 10.42 % |
| Vanguard Fiduciary Trust Co. 7.544 % | 71,611,201 | 7.544 % |
| PNC Investments LLC 5.447 % | 51,709,473 | 5.447 % |
| BlackRock Advisors LLC 5.225 % | 49,601,488 | 5.225 % |
What is the most successful ETF?
| Symbol | Name | 5-Year Return |
|---|---|---|
| VGT | Vanguard Information Technology ETF | 22.83% |
| XHB | SPDR S&P Homebuilders ETF | 22.67% |
| IXN | iShares Global Tech ETF | 22.57% |
| IETC | iShares U.S. Tech Independence Focused ETF | 22.15% |
Is Eli Lilly a good long-term stock?
The Verdict
Its robust pipeline, global presence, and financial stability position it favorably for potential long-term growth. Trading at 50 times forward 2024 earnings, Eli Lilly seems pretty expensive to investors. However, Eli Lilly's growth is not limited to 2024.
Why Eli Lilly stock so high?
Eli Lilly's gains have been fueled largely by a bet that its obesity and diabetes drug portfolio will continue to grow rapidly, with analysts expecting Zepbound and Mounjaro, which share the same active ingredient, to generate more than $40 billion of annual revenue later in the decade.
How often does Eli Lilly pay dividends?
Eli Lilly and Company ( LLY ) pays dividends on a quarterly basis. The next dividend payment is planned on March 8, 2024 . Eli Lilly and Company ( LLY ) has increased its dividends for 10 consecutive years.
Is Eli Lilly a dividend stock?
LLY pays a dividend of $1.3 per share. LLY's annual dividend yield is 0.6%. When is Eli Lilly & Co ex-dividend date? Eli Lilly & Co's upcoming ex-dividend date is on Feb 14, 2024.
What is the highest Eli Lilly stock has ever been?
The all-time high Eli Lilly stock closing price was 782.06 on February 16, 2024. The Eli Lilly 52-week high stock price is 794.47, which is 5.4% above the current share price.
How high can Eli Lilly stock go?
$1,000 A Share, One Analyst Now Says. Wall Street analysts have repeatedly boosted their forecasts for anti-obesity drug sales over the last couple of years—as well as the stock-price targets for the leading makers of these medications, Eli Lilly and Novo Nordisk.
What companies are in VOO S&P 500?
- Apple Inc.
- Microsoft Corporation6.97%
- Amazon.com, Inc.
- NVIDIA Corporation3.05%
- Alphabet Inc. Class A2.06%
- Meta Platforms Inc Class A1.96%
- Alphabet Inc. Class C1.75%
- Tesla, Inc. 1.71%
What is the obesity ETF?
The investment seeks investment results that correspond generally to the performance, before fees and expenses, of an index which is designed to track the performance of companies globally that are positioned to profit from servicing the obese, including biotechnology, pharmaceutical, health care and medical device ...
What company did Eli Lilly buy?
INDIANAPOLIS , Dec. 27, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of POINT Biopharma Global Inc.
Why should I invest in Eli Lilly stock?
Shares of Eli Lilly have risen by roughly 1,190% over the past 10 years. Eli Lilly (LLY -0.52%) has been on a tear this past year, rising up to become the most valuable healthcare stock in the world. It soared past UnitedHealth Group and other top healthcare companies in 2023.
What is the price outlook for Eli Lilly stock?
Based on short-term price targets offered by 20 analysts, the average price target for Eli Lilly comes to $745.55. The forecasts range from a low of $525.00 to a high of $950.00. The average price target represents a decline of 1.6% from the last closing price of $757.64.
How does Eli Lilly make money?
Eli Lilly has focused on patent-protected medicines, with generic manufacturers taking over production of earlier drugs whose patents have expired.
What are the top 5 ETFs to buy?
| Fund (ticker) | YTD performance | 5-year performance |
|---|---|---|
| Vanguard S&P 500 ETF (VOO) | 6.5 percent | 14.6 percent |
| SPDR S&P 500 ETF Trust (SPY) | 6.5 percent | 14.6 percent |
| iShares Core S&P 500 ETF (IVV) | 6.5 percent | 14.6 percent |
| Invesco QQQ Trust (QQQ) | 6.3 percent | 21.1 percent |
Which ETF pays highest dividend?
| Symbol | Name | Dividend Yield |
|---|---|---|
| CYA | Simplify Tail Risk Strategy ETF | 109.43% |
| NGE | Global X MSCI Nigeria ETF | 85.38% |
| TSL | GraniteShares 1.25x Long Tesla Daily ETF | 79.82% |
| KLIP | KraneShares China Internet and Covered Call Strategy ETF | 64.81% |
What is the best ETF for long term growth?
| ETF | Assets | Expense ratio |
|---|---|---|
| Invesco QQQ Trust (QQQ) | $249 billion | 0.20% |
| Vanguard High Dividend Yield Index ETF (VYM) | $51 billion | 0.06% |
| Vanguard Total International Stock ETF (VXUS) | $63 billion | 0.07% |
| Vanguard Total World Stock ETF (VT) | $33 billion | 0.07% |
What is Eli Lilly future outlook?
Future Growth
Eli Lilly is forecast to grow earnings and revenue by 27.2% and 15.6% per annum respectively. EPS is expected to grow by 27.1% per annum. Return on equity is forecast to be 63.5% in 3 years.
Will Eli Lilly become a trillion dollar company?
The $1 trillion club is within reach
Per Eli Lilly's third-quarter earnings report, the company is expecting to generate $33.6 billion in total revenue for 2023 at the midpoint of its guidance. According to analyst estimates, Lilly is expected to grow its top line by about 16% in 2024.
Does Eli Lilly have a moat?
According to Morningstar, “patents, economies of scale, and a powerful distribution network support Eli Lilly's wide moat. Lilly's patent-protected drugs carry strong pricing power, which enables the firm to generate returns on invested capital in excess of its cost of capital.”
